LP32685-7
Carisoprodol+Meprobamate
Active
Description
Carisoprodol (N-isopropylmeprobamate, Soma, ingredient of Soma Compound) is a carbamate derivative first synthesized in 1959 and used clinically as a muscle relaxant and sedative. Carisoprodol is known to be metabolized to meprobamate and hydroxyl-meprobamate.
Meprobamate is the major metabolite of carisoprodol, and is a CNS depressant in its own right, indicated for the management of anxiety disorders or for short-term treatment of anxiety symptoms. Use of these drugs begins with a prescription for muscular pain or anxiety, and abuse may develop for the sedative-hypnotic effects.
Source: LOINC partner 1
Basic Part Properties
- Part Display Name
- Carisoprodol+Meprobamate
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2003-10-23
- Construct for LOINC Short Name
- Carisoprodol+Meprob
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP32685-7
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 异丙基甲丁双脲+氨甲丙二酯 |
| fr-CA | French (Canada) | Carisoprodol+Méprobamate |
| et-EE | Estonian (Estonia) | Karisoprodool + meprobamaat |
| es-ES | Spanish (Spain) | Carisoprodol+Meprobamato |
| it-IT | Italian (Italy) | Carisoprodol+Meprobamato |
| tr-TR | Turkish (Turkey) | Karizoprodol+Meprobamat |
| ru-RU | Russian (Russian Federation) | Каризопродол+Мепробамат |
| nl-NL | Dutch (Netherlands) | carisoprodol + meprobamaat |
| fr-BE | French (Belgium) | Carisoprodol+Méprobamate |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright